Model Number INSULIN |
Device Problem
High Test Results (2457)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 09/24/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
This event occurred in (b)(6).The customer collected negative mixed serum samples and performed dilution tests for troubleshooting purposes.The insulin results for these samples were approximately 4.3 uu/ml and were diluted 20, 40 and 80 times respectively with the following results: 194.6 uu/ml (calculated result 3892 uu/ml), 115.1 uu/ml (calculated result 4604 uu/ml) and 56.99 uu/ml (calculated result 4559.2 uu/ml).The customer concluded there were endogenous interfering substances in the samples resulting in non-specific binding of the reaction process affecting the insulin results.The investigation is ongoing.
|
|
Event Description
|
The initial reporter questioned a high result not corresponding to the clinical picture for 1 patient sample tested for elecsys insulin (insulin) on a cobas 6000 e 601 module.The insulin result was > 1000 uu/ml.This result was reported outside of the laboratory.The patient's c-peptide result was normal at 1.02 nmol/l.The customer also checked other results from the patient: free-kap was 40.200 mg/l and free lam was 1090.000 mg/l.These results are used in the clinical diagnosis and monitoring of multiple myeloma.The customer suspects an interference in the patient sample affecting the insulin results based on the high free-kap and free lam results.The e601 module serial number was (b)(4).
|
|
Manufacturer Narrative
|
Based on the calibration and qc data provided, a general reagent issue is excluded.The alarm trace from (b)(6)2019 shows several messages related to sample quality.There was no sample available for further investigation.The investigation did not identify a product problem.The cause of the event could not be determined.
|
|
Search Alerts/Recalls
|